Skip to main content
ONCOSEM ONKOLOJİK SİSTEMLER SANAYİ VE TİCARET A.Ş. logo

ONCOSEM ONKOLOJİK SİSTEMLER SANAYİ VE TİCARET A.Ş. — Investor Relations & Filings

Ticker · ONCSM ISIN · TREONCO00018 LEI · 789000OLLYVUPAGBBH28 IS Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country TR Türkiye
Listing IS ONCSM

About ONCOSEM ONKOLOJİK SİSTEMLER SANAYİ VE TİCARET A.Ş.

https://www.oncosem.com

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş. is a manufacturer of medical devices and systems specializing in oncology. The company's core focus is on the development and production of solutions for the preparation and administration of chemotherapy drugs. Its product portfolio includes fully automatic chemotherapy drug preparation systems, smart software, and closed-system drug transfer devices. Additionally, Oncosem produces a range of related consumables such as chemotherapy preparation kits, IV infusion systems, needle-free connectors, infusion pumps, and specialized waste systems. The company's offerings are designed to enhance safety and efficiency in cancer treatment protocols.

Recent filings

Filing Released Lang Actions
Regarding the Amendment of Article 19 of the Articles of Association
Regulatory Filings
2026-04-30 Turkish
Regarding the Amendment of Article 19 of the Articles of Association
Regulatory Filings
2026-04-30 Turkish
Şirketimizin Kayıtlı Sermaye Tavanı Geçerlilik Süresinin Uzatılması Hk.
Regulatory Filings
2026-04-30 Turkish
Şirketimizin Kayıtlı Sermaye Tavanı Geçerlilik Süresinin Uzatılması Hk.
Regulatory Filings
2026-04-30 Turkish
Regarding the Establishment of a New Business Relationship / Signing of a Contract
Regulatory Filings Classification · 1% confidence The document is a corporate announcement of a new business relation (contract award) with Gaziantep University’s hospital, including tender participation, contract amount, and expected start date. It is not an annual or interim financial report, earnings release, management change, dividend notice, M&A document, or any other specialized category. It is a general public disclosure under the company’s regulatory filing system. Therefore it falls under the fallback category of Regulatory Filings (RNS).
2026-04-16 English
On Common and Continuous Related Party Transactions
Regulatory Filings Classification · 1% confidence The document is a public disclosure on the Turkish Public Disclosure Platform (KAP) about the Board of Directors’ approval of a related party transactions report required under Capital Markets Board Communiqué II-17.1 Article 10. It is not an earnings release, management change, dividend notice or standard financial report, but a regulatory announcement of a specific compliance report. There is no detailed financial statements as in an Annual or Interim Report, nor is it a simple announcement of an upcoming report (it is the disclosure itself). It therefore falls under the general regulatory filings category (RNS).
2026-04-10 Turkish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.